Showing all 3 results
-
Add to cart4-16 week supply
A 40mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.
Produced for laboratory research only. Not for human or veterinary consumption.Each Retatrutide 40mg Research kit includes:
Pre-filled Research pen (40mg Retatrutide)
Research information sheet
Storage:
Store refrigerated (2–8°C). Do not freeze.
Supplied in fixed-volume sealed format for laboratory analysis.Delivery: Dispatched with a cold pack.
Tracked 2 DAY UK Delivery.Research & Development purposes only
-
Add to cartProduct Characteristic Specification Details Brand Name Mounjaro Bundle (Maintenance Phase) Active Ingredient Tirzepatide Available Strengths 10mg and 12.5mg pre-filled injection pens Therapeutic Class Dual GIP and GLP-1 Receptor Agonist Primary Indication Chronic Weight Management & Type 2 Diabetes Support Administration Route Subcutaneous Injection (Once Weekly) Packaging Configuration Multi-pen multi-month treatment bundle Storage Temperature Refrigerated ($2^\circ\text{C}$ to $8^\circ\text{C}$), do not freeze -
Add to cartSpecification Details Product Name Retatrutide Injection Pen Kit Concentration 40mg Form Type Prefilled Injection Pen Primary Indication Chronic Weight Management & Metabolic Support Mechanism of Action Triple Hormone Receptor Agonist (GIP, GLP-1, Glucagon) Storage Temperature Refrigerated at 2°C to 8°C (Do not freeze) Administration Route Subcutaneous Injection